CDH2 and cancer: In contrast, VPA significantly enhances cancer cell migration and invasion in vitro, and it can activate EMT in CRC cell lines, resulting in downregulation of epithelial markers: E-cadherin and ZO-1, and upregulation of mesenchymal markers: N-cadherin and fibronectin.